Nrx pharmaceutical's (nasdaq:nrxp) chairman dr. jonathan javitt to present at the ketamine 2024 conference in oxford, uk

Radnor, pa. , march 25, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq:nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, today announced that dr. jonathan javitt, chairman and chief scientist of nrx pharmaceuticals and co-ceo of hope therapeutics, will present at the ketamine 2024 conference, which is planned for march 25-27, 2024, at the blavatnik school of government in oxford, uk.
NRXP Ratings Summary
NRXP Quant Ranking